MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-KL-01-0004184
Sangrose Laboratories Private Limited - pharma in Alappuzha, Kerala, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹32.28 Cr
▲ 34% YoY
Net profit · FY 2024
₹6.23 Cr
Net margin 19.3%
EBITDA · FY 2024
₹9.75 Cr
EBITDA margin 30.2%
Authorised capital
₹90 Lakh
Registered with MCA
Paid-up capital
₹38.31 Lakh
Issued & subscribed
Open charges
₹1.87 Cr
Satisfied ₹1.52 Cr
Company age
30 yrs
Est. 1996
Employees · EPFO
128
Provident fund records
About Sangrose Laboratories Private Limited
Data last updated:
Sangrose Laboratories Private Limited is a private limited company based in Alappuzha, Kerala, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 01 March 1996 and has been in existence for over 30 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U24231KL1996PTC010099. Its GSTIN is 32AADCS4768F1ZD (Kerala). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹90 Lakh and a paid-up capital of ₹38.31 Lakh. It is led by directors including Alexander Chackalamuriyil Kunjummen (Managing Director) and Thomas Alexander (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Industrial Estatemavelikkara Kallimel P O, Alappuzha, Kerala, India – 690570.
As per the financials filed for FY 2024, the company reported a revenue of ₹32.28 Cr, a growth of 34% compared to the previous year. For the same year it recorded a net profit of ₹6.23 Cr (net margin 19.3%) and EBITDA of ₹9.75 Cr (EBITDA margin 30.2%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 5% over five years.
The company has about 128 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹1.87 Cr and satisfied charges of ₹1.52 Cr on record. Court records list 8 cases involving the company, including 7 filed by the company and 1 filed against it; 2 cases are pending.
Sangrose Laboratories Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-KL-01-0004184). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sangroselabs.com.
Company details
CIN U24231KL1996PTC010099
Registration Number 010099
Incorporation Date 01 March 1996
ROC Ernakulam
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-KL-01-0004184
Key People
Alexander Chackalamuriyil Kunjummen Managing Director Thomas Alexander Whole-Time Director George Mathew Director Recognitions & Rankings of Sangrose Laboratories
Contact details
Sangrose Laboratories Private Limited's registered office is in Alappuzha, Kerala. Its website is sangroselabs.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressIndustrial Estatemavelikkara Kallimel P O, Alappuzha, Kerala, India – 690570
- IndustryPharma, API Manufacturers, Drug Formulation & Development
To see the full contact details of Sangrose Laboratories Private Limited, buy the company report.
Comprehensive company report
Sangrose Laboratories Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Sangrose Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Sangrose Laboratories Private Limited, buy the company report.
Financials of Sangrose Laboratories Private Limited
FY 2025 filings availableSangrose Laboratories Private Limited reported revenue of ₹32.28 Cr (up 34% YoY) for FY 2024.
Revenue · FY 2024
₹32.28 Cr ▲ 34%
Net profit · FY 2024
₹6.23 Cr margin 19.3%
EBITDA · FY 2024
₹9.75 Cr margin 30.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 34%
3 years · compounded
▲ 5%
5 years · compounded
▲ 5%
EBITDA CAGR growth
1 year
▲ 130%
3 years · compounded
▲ 30%
5 years · compounded
▲ 21%
Revenue has grown at a compounded annual rate (CAGR) of 5% over five years, including 34% growth in the latest year. EBITDA rose 130% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹9.75 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹6.23 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 30.2% | ||||
| Net Profit Margin | 19.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sangrose Laboratories Private Limited, buy the company report.
Board of directors of Sangrose Laboratories Private Limited
Sangrose Laboratories has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Alexander Chackalamuriyil Kunjummen Also directs: Sangros Drugchem Private Limited | Managing Director | 01 Mar 1996 | 30 Years 7 Months | Current |
| George Mathew | Director | 01 Mar 1996 | 30 Years 7 Months | Current |
| Chackalamuryil Kunjummen Joseph | Director | 05 Sep 2001 | 25 Years 1 Months | Current |
| Thomas Alexander Also directs: Sangros Drugchem Private Limited | Whole-Time Director | 25 Feb 2002 | 24 Years 8 Months | Current |
Peer comparison
Sangrose Laboratories Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (API Manufacturers, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vaidhatru Pharma Private Limited | ₹32.48 Cr (FY 2024) | -8.0% | Hyderabad, Telangana, India | |||
| Deccan Nutraceuticals Private Limited | ₹32.43 Cr (FY 2024) | 32.0% | Pune, Maharashtra, India | |||
| Biolab Diagnostics (India ) Private Limited | ₹32.43 Cr (FY 2025) | 2.0% | Mumbai, Maharashtra, India | |||
| Relax Biotech Private Limited | ₹32.39 Cr (FY 2024) | -12.0% | Vadodara, Gujarat, India | |||
| Sangrose Laboratories Private Limitedthis company | ₹32.28 Cr (FY 2024) | ₹6.23 Cr | 19.3% | 34.0% | 128 | Alappuzha, Kerala, India |
| Adora Products Private Limited | ₹32.02 Cr (FY 2024) | 43.0% | Aurangabad, Maharashtra, India | |||
| Dano Vaccines and Biologicals Pvt Ltd | ₹31.96 Cr (FY 2025) | 3.0% | Hyderabad.Andhra Pradesh, Telangana, India | |||
| Torrvis Pharmaceuticals Private Limited | ₹31.91 Cr (FY 2025) | 12.0% | Delhi, India |
To see the full peer comparison of Sangrose Laboratories Private Limited, buy the company report.
Auditor
Sangrose Laboratories Private Limited is audited by P K Raju & Company for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| P K Raju & Company | FY 2023 | 003484S |
Shareholding
The shareholding of Sangrose Laboratories Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sangrose Laboratories Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1.87 Cr
Satisfied charges
₹1.52 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 17 Jan 1994 | 90016114 | State Bank of India | ₹1.87 Cr | Open | |
| 03 Sep 2013 | 10446500 | Kerala Financial Corporation | ₹76.75 Lakh | Satisfied | |
| 01 Jul 2003 | 90019237 | Kerala Financial Corporation | ₹75 Lakh | Satisfied |
To see the full charge records of Sangrose Laboratories Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
Sangrose Laboratories Private Limited has 8 court cases on record: 7 filed by Sangrose Laboratories, 1 filed against it. 2 cases are pending and 6 are disposed.
Total cases
8
Filed by the company
7
Filed against the company
1
Pending
2
Disposed
6
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 7 | 0 | 2 |
| District courts | 1 | 1 | 0 |
Cases on record (5 of 8)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court | Writ petition | Filed by the company against State of Kerala and 1 other | Pending |
| High Court | Writ petition | Filed by the company against Environmental Engineer, Kerala State Pollution Control Board | Disposed |
| High Court | Writ petition | Filed by the company against State of Kerala and 3 others | Disposed |
| District court, Thiruvananthapuram, Kerala | Criminal complaint | Filed against the company by an individual | Disposed |
| High Court | Petition | Filed by the company against an individual | Disposed |
To see the full case history of Sangrose Laboratories Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Sangrose Laboratories Private Limited has 4 MSME Form 1 returns on record between 2019 and 2023, listing 22 overdue payments to 13 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 13)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Deccan Nutraceuticals Private Limited | |||
| Raksh Bio Science Private Limited | |||
| an individual supplier | |||
| Indian Cork Mills Private Limited |
To see the full MSME payment records of Sangrose Laboratories Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Sangrose Laboratories Private Limited has a workforce of 128 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.
Employee count
128
Active EPFO establishments
1
Employee growth
2.4%
GST
Sangrose Laboratories has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AADCS4768F1ZD | Kerala | Active | 01 Jul 2017 |
| 33AADCS4768F1ZB | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sangrose Laboratories Private Limited, buy the company report.
Recent activity
Sangrose Laboratories Private Limited has 5 board changes on record since 1996: 4 appointments and 1 cessation. The latest: Thomas Alexander ceased to be Director on 30 Sep 2024.
AGM
Sangrose Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Sangrose Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ernakulam.
Ceased
Thomas Alexander ceased to be Director.
Charges
A charge registered on 03 Sep 2013 via Charge ID 10446500 with Kerala Financial Corporation was fully satisfied on 26 Oct 2022.
Charges
A charge with State Bank Of India of Rs. 187.00 Lakh registered on 17 Jan 1994 with Charge ID 90016114 was modified on 16 Jun 2021.
Charges
A charge with Kerala Financial Corporation amounted to Rs. 76.75 Lakh with Charge ID 10446500 was registered on 03 Sep 2013.
Charges
A charge registered on 01 Jul 2003 via Charge ID 90019237 with Kerala Financial Corporation was fully satisfied on 18 Jun 2013.
Charges
A charge with Kerala Financial Corporation of Rs. 75.00 Lakh registered on 01 Jul 2003 with Charge ID 90019237 was modified on 02 Jul 2003.
Charges
A charge with Kerala Financial Corporation amounted to Rs. 75.00 Lakh with Charge ID 90019237 was registered on 01 Jul 2003.
Appointed
Thomas Alexander was appointed as Whole-Time Director.
Appointed
Chackalamuryil Kunjummen Joseph was appointed as Director.
Appointed
Alexander Chackalamuriyil Kunjummen was appointed as Managing Director.
3 earlier events are in the company report.
Frequently asked questions
Sangrose Laboratories is an active private limited company based in Alappuzha, Kerala, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 01 March 1996 (30+ years old) and is registered under CIN U24231KL1996PTC010099.
Sangrose Laboratories has 4 current directors:
- Alexander Chackalamuriyil Kunjummen - Managing Director
- Thomas Alexander - Whole-Time Director
- George Mathew - Director
- Chackalamuryil Kunjummen Joseph - Director
The latest financial statements of Sangrose Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Sangrose Laboratories is 32AADCS4768F1ZD, registered in Kerala. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 33AADCS4768F1ZB (Tamil Nadu).
The CIN (Corporate Identification Number) of Sangrose Laboratories is U24231KL1996PTC010099. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sangrose Laboratories has 8 court cases on record: 7 filed by the company and 1 filed against it. 2 are pending. Most are in the high courts.
Sangrose Laboratories was incorporated on 01 March 1996, making it 30+ years old. It is registered with the Registrar of Companies, Ernakulam.
The peers of Sangrose Laboratories by revenue are Vaidhatru Pharma Private Limited, Deccan Nutraceuticals Private Limited, Biolab Diagnostics (India ) Private Limited, Relax Biotech Private Limited, Adora Products Private Limited and 2 more, all in the Pharma industry (API Manufacturers, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Thomas Alexander ceased to be Director on 30 Sep 2024. Thomas Alexander was appointed as Whole-Time Director on 25 Feb 2002. Chackalamuryil Kunjummen Joseph was appointed as Director on 05 Sep 2001. Sangrose Laboratories has 5 board changes on record in total.
Yes, Sangrose Laboratories is registered as a small enterprise under Udyam registration (number: UDYAM-KL-01-0004184).
Sangrose Laboratories has 4 MSME Form 1 returns on record between 2019 and 2023, listing 22 overdue payments to 13 micro and small suppliers. The latest return was filed on 26 Dec 2023.
Sangrose Laboratories can be reached through the website sangroselabs.com. Its registered office is in Alappuzha, Kerala, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages